Switzerland-based online banking and trading company Swissquote (SWX:SQN) has launched the Swissquote Cancer Fighters Index.
The Swissquote Cancer Fighters Index is a strategic collection of leading companies advancing oncology through cutting-edge technologies and groundbreaking therapies and reshaping the outcomes for millions of patients worldwide.
Key Focus Areas of the Portfolio:
- Targeted Therapies: Precision treatments that directly attack cancer cells while minimising harm to healthy tissues, ushering in a new era of personalised medicine;
- Immunotherapy: Harnessing the body’s immune system to combat cancer with game-changing drugs like CAR-T cell therapies and immune checkpoint inhibitors;
- Early Detection: Non-invasive diagnostic tools and liquid biopsies that detect cancer at its most treatable stages;
- Next-Generation Vaccines: Pioneering mRNA and other innovative vaccine technologies aimed at preventing or treating cancer.
The Swissquote Cancer Fighters Index offers investors a unique opportunity to align with global leaders driving life-changing innovations in cancer care.
